Skip to search formSkip to main contentSkip to account menu

epoetin delta

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
Aims/hypothesis: Diabetic retinopathy is the result of increased oxidative and nitrosative stress induced by chronic… 
2010
2010
Erythropoietin (EPO) exerts (renal) tissue protective effects. Since it is unclear whether this is a direct effect of EPO on the… 
2010
2010
Background/Aims:Erythropoiesis-stimulating agents (ESAs) may have therapeutic benefits beyond ameliorating anemia. Although ESAs… 
2010
2010
Background Erythropoiesis stimulating agents (ESAs) are widely used to treat anaemia but concerns exist about their potential to… 
2010
2010
Erythropoiesis-stimulating agents (ESAs) are used to treat anemia associated with renal failure. It is now known that these… 
2007
2007
ABSTRACT Objective: To demonstrate safety and efficacy of epoetin delta for the management of anaemia in predialysis patients… 
2006
2006
Epoetin delta (Dynepo ® , Shire plc) is the only erythropoietin synthesized in a human cell line. Currently available…